Piroxicam repurposing approach as an anti-virulence agent against methicillin resistant <i>Staphylococcus aureus</i> clinical isolates
Last updated: 04 Jan 2025
10.21608/mid.2024.271311.1805
MRSA, Anti-virulence, piroxicam, biofilm formation, agr system
Ingy
El-Soudany
Ibrahim
Microbiology and Immunology Department, Faculty of Pharmacy, Pharos University in Alexandria, Egypt
ingy.elsoudany@pua.edu.eg
Alexandria
0000-0001-9602-0185
Maged
Elsawy
Pharmaceutical Chemistry department, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt
maged.elsawy@pua.edu.eg
Alexandria
Rasha
Emad
Alexandria Main University Hospital Champollion street, Al Attarin, Alexandria, Egypt
gs-rasha.emad@alexu.edu.eg
Alexandria
0000-0002-8774-6635
Nancy
Attia
Mohamed
Microbiology department, Medical Research Institute, Alexandria University, Alexandria, Egypt
nancy.attia@alexu.edu.eg
Alexandria
0000-0002-8738-1007
5
2
47401
2024-05-01
2024-02-19
2024-05-01
636
650
2682-4132
2682-4140
https://mid.journals.ekb.eg/article_345839.html
https://mid.journals.ekb.eg/service?article_code=345839
21
Original Article
1,157
Journal
Microbes and Infectious Diseases
https://mid.journals.ekb.eg/
Piroxicam repurposing approach as an anti-virulence agent against methicillin resistant <i>Staphylococcus aureus</i> clinical isolates
Details
Type
Article
Created At
25 Dec 2024